Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study

BACKGROUND: The addition of cetuximab (CTX) to perioperative chemotherapy (CT) for operable colorectal liver metastases resulted in a shorter progression-free survival. Details of disease progression are described to further inform the primary study outcome. METHODS: A total of 257 KRAS wild-type pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Pugh, Siân A, Bowers, Megan, Ball, Alexandre, Falk, Stephen, Finch-Jones, Meg, Valle, Juan W, O'Reilly, Derek A, Siriwardena, Ajith K, Hornbuckle, Joanne, Rees, Myrddin, Rees, Charlotte, Iveson, Tim, Hickish, Tamas, Maishman, Tom, Stanton, Louise, Dixon, Elizabeth, Corkhill, Andrea, Radford, Mike, Garden, O James, Cunningham, David, Maughan, Tim S, Bridgewater, John A, Primrose, John N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985352/
https://www.ncbi.nlm.nih.gov/pubmed/27434036
http://dx.doi.org/10.1038/bjc.2016.208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985352/
https://www.ncbi.nlm.nih.gov/pubmed/27434036
http://dx.doi.org/10.1038/bjc.2016.208

Ejemplares similares